Z-1723-2014 Class II Terminated

Recalled by Medtronic Neuromodulation — Minneapolis, MN

FDA device recall Z-1723-2014 was initiated by Medtronic Neuromodulation on May 2, 2014 and is designated Class II. Reason for recall: Medtronic has determined that an Ascenda catheter kit may have had endotoxin in excess of USP limits. The recall status is terminated (terminated Oct 7, 2014). Affected quantity: 1.

Recall Details

Product Type
Devices
Report Date
Jun 11, 2014
Initiation Date
May 2, 2014
Termination Date
Oct 7, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1

Product Description

Medtronic Model 8780 Ascenda Intrathecal Catheter. The implantable Medtronic Model 8780 Ascenda Intrathecal Catheter is part of an infusion system that stores and delivers parenteral drugs to the intrathecal space. The implanted infusion system components consist of a Medtronic pump and a Model 8780 Ascenda Intrathecal Catheter.

Reason for Recall

Medtronic has determined that an Ascenda catheter kit may have had endotoxin in excess of USP limits.

Distribution Pattern

Distributed in the state of CT.

Code Information

N457062003

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1723-2014
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 26, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.